ALL >> Business >> View Article
Chandra Bhagat Pharma Limited Ipo Details

Chandra Bhagat Pharma Limited IPO membership period from Jan 31 to Feb 6, 2020:
 
Chandra Bhagat Pharma Limited launched in 2003. The organization associated with the lifesaving prescriptions advertise in India. It delivered meds like Cardiovascular, Antineoplastic, Antibiotics and Hormone medications. The organization presented another IPO in Small and Medium-sized Enterprises (SME). The IPO membership period will begin on 31st Jan and it will end on sixth Feb 2020.
 
Chandra Bhagat Pharma Limited IPO Details:
 
Offer Period: Jan 31 to Feb 6, 2020
 
Initial public offering Type: Fixed Price Issue
 
Initial public offering Size: 2,000,000 Eq Shares of Rs 10 (amassing up to Rs 10.20 cr)
 
Face Value: Rs 10 Per Eq Share
 
Issue Price: Rs 51 Per Eq Share
 
Market Lot: 2000 Shares
 
Min Order Quantity: 2000 Shares
 
Posting At: BSE SME
 
It is a Fixed Price Issue type of IPO with the assumed worth of Rs 10 for every value share. At first, the size of the IPO is 2,000,000 value portions of Rs 10 with ...
... amassing up to Rs 10.20 crore. The offered cost of the IPO is Rs 51 for each value share at the hour of membership. Additionally, the market Lot of the CBC Pharma IPO is 2000 offers. Likewise, the base request amount is 2000 offers (1 parcel) and the cost of the part is about Rs 102,000.
 
Promoter Holdings:
 
The advertisers or lead directors of the organization are Hemant Chandravadan Bhagat and Pranav Hemant Bhagat.
 
Pre Issue Share Holding: 96.72%
 
Post Issue Share Holding: 71.08%
 
The target of the organization, it intends to use the raised sum for the development of working capital, to orchestrate appropriation and warehousing focuses, IPO costs and general corporate purposes. The IPO will be recorded on BSE SME on Feb 14, 2020. On eleventh Feb, the designation request will be given.
 
Registrar:
Connection Intime India Pvt Ltd
 
C 101, 247 Park, L.B.S.Marg,
 
Vikhroli (West), Mumbai – 400083
 
Telephone: +91-22-4918 6270
 
Email: cbpl.ipo@linktime.co.in
 
Site: http://www.linktime.co.in
 
Disclaimer: This post is only data about the IPO. It doesn't offer any guidance or proposal. If it's not too much trouble read the offer archive cautiously and counsel your guide before contributing.
https://expertviews.weebly.com/stock-investor/chandra-bhagat-pharma-limited-ipo-details
Add Comment
Business Articles
1. Why Multi-model Strategies Are The Next Competitive Edge For Ai StartupsAuthor: HashRoot
2. Fast Cash Loans Obtained Online Are Excellent For Meeting Unforeseen Needs
Author: Lucy Lloyd
3. Building Organizational Resilience: The Importance Of Effective Bcms Implementation
Author: kohan
4. Triethyl Citrate Manufacturers
Author: TKM Pharma
5. Arizona Events Made Accessible With Reliable Ada-compliant Restroom Solutions
Author: Alice Brin
6. Driving Corporate Responsibility: How The Top Sustainability And Esg Consulting Firm In The Uae Shapes A Greener Future
Author: kohan
7. Hire Led Advertising Screen And Mobile Led Screen Van In Birmingham – Promote Your Brand With Eye-catching Digital Displays
Author: Vikram kumar
8. Diy Vs. Professional House Cleaning – Which One Saves You More?
Author: Smita Jain
9. Lucintel Forecasts The Global High Performance Deep Cycle Battery Market To Grow With A Cagr Of 7.8% From 2024 To 2030
Author: Lucintel LLC
10. Lucintel Forecasts The Global Electric Vehicle Sound Generator Market To Grow With A Cagr Of 15% From 2024 To 2030
Author: Lucintel LLC
11. Lucintel Forecasts The Global Electric Vehicle Liquid Cooling Plate Market To Grow With A Cagr Of 16.8% From 2025 To 2031
Author: Lucintel LLC
12. Turning Industrial Waste Into Eco-friendly High-performance Fabrics | Texnic
Author: CubeEYE
13. Lucintel Forecasts The Global Battery Swapping Infrastructure Market To Grow With A Cagr Of 22.1% From 2025 To 2031
Author: Lucintel LLC
14. Future Of Content Syndication: Ai, Personalization & Predictive Targeting
Author: Edge Link
15. Lucintel Forecasts The Global Battery Powered Surgical Drill Market To Grow With A Cagr Of 5.2% From 2025 To 2031
Author: Lucintel LLC

 
  
 




